The most common side effects are stomach and bowel symptoms: nausea, diarrhea, vomiting, constipation, indigestion and stomach pain. In the US prescribing information for tirzepatide for weight management (US brand name Zepbound, revised August 2026), two pooled 72-week trials reported, depending on dose, nausea in 25-29% (placebo 8%), diarrhea in 19-23% (placebo 8%), vomiting in 8-13% (placebo 2%) and constipation in 11-17% (placebo 5%).
Most of these symptoms appeared while the dose was being increased and eased over time, and 1.9-4.3% of people stopped the medicine because of them, depending on dose (placebo 0.5%). The injection site may become red or itchy.
Less often, gallstones or gallbladder inflammation (gallbladder inflammation 0.7%, placebo 0.2%), pancreatitis, and reduced kidney function from fluid loss due to vomiting or diarrhea can occur. Low blood sugar becomes more common with insulin or sulfonylurea diabetes medicines: in the trial of adults with type 2 diabetes, 10.3% of those also taking a sulfonylurea had low blood sugar, compared with 2.1% of those who were not. If you take these medicines, we decide together at prescribing whether to lower their dose.
- If you feel sick: eat small portions slowly and stop when you feel full. Cut back on greasy food and sip water often
- If symptoms are severe: the next dose increase can be postponed or the dose adjusted. Do not change the dose on your own; we decide it at your visit
- Seek care right away for: severe stomach pain that keeps spreading to the back (possible pancreatitis); upper right stomach pain with fever, or yellowing of the eyes or skin (possible gallbladder problem); vomiting or diarrhea so persistent you cannot keep water down and pass much less urine; or an allergic reaction with shortness of breath or swelling of the face or throat